# | Title | Journal | Year | Citations |
---|
1 | TGF-β: the master regulator of fibrosis | Nature Reviews Nephrology | 2016 | 2,269 |
2 | The global epidemiology of hypertension | Nature Reviews Nephrology | 2020 | 1,530 |
3 | Glycosylation in health and disease | Nature Reviews Nephrology | 2019 | 1,166 |
4 | Cellular and molecular mechanisms of renal fibrosis | Nature Reviews Nephrology | 2011 | 1,067 |
5 | Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup | Nature Reviews Nephrology | 2017 | 946 |
6 | Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy | Nature Reviews Nephrology | 2011 | 845 |
7 | Pre-eclampsia part 1: current understanding of its pathophysiology | Nature Reviews Nephrology | 2014 | 786 |
8 | Mitochondrial energetics in the kidney | Nature Reviews Nephrology | 2017 | 758 |
9 | Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases | Nature Reviews Nephrology | 2018 | 725 |
10 | Global epidemiology and outcomes of acute kidney injury | Nature Reviews Nephrology | 2018 | 698 |
11 | The immunology of atherosclerosis | Nature Reviews Nephrology | 2017 | 667 |
12 | Genetics of diabetes mellitus and diabetes complications | Nature Reviews Nephrology | 2020 | 657 |
13 | Pre-eclampsia: pathogenesis, novel diagnostics and therapies | Nature Reviews Nephrology | 2019 | 609 |
14 | Pathophysiology of ischemic acute kidney injury | Nature Reviews Nephrology | 2011 | 602 |
15 | Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD | Nature Reviews Nephrology | 2015 | 574 |
16 | Acute kidney injury—epidemiology, outcomes and economics | Nature Reviews Nephrology | 2014 | 564 |
17 | Macrophages: versatile players in renal inflammation and fibrosis | Nature Reviews Nephrology | 2019 | 551 |
18 | Cellular signalling by primary cilia in development, organ function and disease | Nature Reviews Nephrology | 2019 | 533 |
19 | Inflammatory processes in renal fibrosis | Nature Reviews Nephrology | 2014 | 531 |
20 | Advances in the understanding and treatment of sepsis-induced immunosuppression | Nature Reviews Nephrology | 2018 | 520 |
21 | Renal fibrosis: novel insights into mechanisms and therapeutic targets | Nature Reviews Nephrology | 2010 | 517 |
22 | Glomerular hyperfiltration: definitions, mechanisms and clinical implications | Nature Reviews Nephrology | 2012 | 512 |
23 | Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease | Nature Reviews Nephrology | 2018 | 473 |
24 | COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup | Nature Reviews Nephrology | 2020 | 466 |
25 | Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis | Nature Reviews Nephrology | 2016 | 461 |
26 | Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | Nature Reviews Nephrology | 2012 | 448 |
27 | Mechanisms of muscle wasting in chronic kidney disease | Nature Reviews Nephrology | 2014 | 444 |
28 | Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 | Nature Reviews Nephrology | 2021 | 444 |
29 | CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease | Nature Reviews Nephrology | 2018 | 442 |
30 | Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease | Nature Reviews Nephrology | 2016 | 441 |
31 | Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment | Nature Reviews Nephrology | 2017 | 436 |
32 | Targeting the progression of chronic kidney disease | Nature Reviews Nephrology | 2020 | 428 |
33 | Complement in disease: a defence system turning offensive | Nature Reviews Nephrology | 2016 | 427 |
34 | Heart failure and kidney dysfunction: epidemiology, mechanisms and management | Nature Reviews Nephrology | 2016 | 422 |
35 | The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease | Nature Reviews Nephrology | 2018 | 413 |
36 | The Klotho proteins in health and disease | Nature Reviews Nephrology | 2019 | 406 |
37 | Immune cell dysfunction and inflammation in end-stage renal disease | Nature Reviews Nephrology | 2013 | 405 |
38 | Fluid balance and acute kidney injury | Nature Reviews Nephrology | 2010 | 402 |
39 | Kidney involvement in COVID-19 and rationale for extracorporeal therapies | Nature Reviews Nephrology | 2020 | 401 |
40 | Renal, metabolic and cardiovascular considerations of SGLT2 inhibition | Nature Reviews Nephrology | 2017 | 398 |
41 | Mechanisms and treatment of organ failure in sepsis | Nature Reviews Nephrology | 2018 | 395 |
42 | Changes in the worldwide epidemiology of peritoneal dialysis | Nature Reviews Nephrology | 2017 | 384 |
43 | Immune cells in experimental acute kidney injury | Nature Reviews Nephrology | 2015 | 382 |
44 | Single-cell RNA sequencing for the study of development, physiology and disease | Nature Reviews Nephrology | 2018 | 369 |
45 | The role of neutrophils and NETosis in autoimmune and renal diseases | Nature Reviews Nephrology | 2016 | 368 |
46 | Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases | Nature Reviews Nephrology | 2017 | 353 |
47 | Mitochondrial dysfunction in diabetic kidney disease | Nature Reviews Nephrology | 2018 | 345 |
48 | Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery | Nature Reviews Nephrology | 2017 | 341 |
49 | Obesity, kidney dysfunction and hypertension: mechanistic links | Nature Reviews Nephrology | 2019 | 336 |
50 | Acute kidney injury: what's the prognosis? | Nature Reviews Nephrology | 2011 | 335 |